Cojutti Piergiorgio, Arnoldo Luca, Cattani Giovanni, Brusaferro Silvio, Pea Federico
Institute of Clinical Pharmacology, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Udine, Italy.
Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy.
Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1070-8. doi: 10.1002/pds.4026. Epub 2016 May 17.
The aim of this point-prevalence study was to assess the occurrence of polypharmacy and hyperpolypharmacy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in different health-care settings of the Friuli-Venezia Giulia region in the North-East of Italy.
Prescription pattern of elderly (65-79 years) and very elderly (>79 years) patients in three different health-care settings [hospitals, general practitioners, and long-term care facilities (LTCFs)] was assessed in March 2014, and PIPs were assessed according to the Beers criteria. Other situations at potentially high risk were checked.
A total of 1582 patients (hospital, n = 528; outpatients, n = 527; nursing homes, n = 527) were included. Very elderly were more represented in hospitals (60.4%) and LTCFs (77.1%) than among general practitioners (37.6%). Polypharmacy and hyperpolypharmacy rates ranged 57.7-73.7% and 9.7-15.6%, respectively. The most frequently prescribed drugs were the proton pump inhibitors, whereas the most common PIPs resulted the benzodiazepines. Multinomial regression analysis showed that female sex, age > 79 years, hyperpolypharmacy, and chronic kidney disease were associated with the risk of having ≥2 PIPs. Two situations at high risk of PIPs not contemplated by the Beers criteria were recurrent in the study population and concerned the statins and metformin.
Polypharmacy and hyperpolypharmacy among elderly and very elderly are strictly associated with the risk of multiple PIPs. The findings offer the opportunity to remark that improvement of the knowledge of safe drug use is generally needed in aging societies and may become of utmost relevance among health-care workers operating in LTCFs. Copyright © 2016 John Wiley & Sons, Ltd.
本现况研究旨在评估意大利东北部弗留利-威尼斯朱利亚地区不同医疗环境下老年和高龄患者中多重用药和超多重用药的发生率以及潜在不适当处方(PIP)的风险。
2014年3月评估了老年(65 - 79岁)和高龄(>79岁)患者在三种不同医疗环境[医院、全科医生和长期护理机构(LTCF)]中的处方模式,并根据Beers标准评估PIP。检查了其他潜在高风险情况。
共纳入1582例患者(医院528例;门诊患者527例;养老院527例)。高龄患者在医院(60.4%)和LTCF(77.1%)中的占比高于全科医生(37.6%)。多重用药和超多重用药率分别为57.7 - 73.7%和9.7 - 15.6%。最常处方的药物是质子泵抑制剂,而最常见的PIP是苯二氮䓬类药物。多项回归分析表明,女性、年龄>79岁、超多重用药和慢性肾病与有≥2种PIP的风险相关。研究人群中反复出现两种Beers标准未考虑的PIP高风险情况,涉及他汀类药物和二甲双胍。
老年和高龄患者中的多重用药和超多重用药与多种PIP的风险密切相关。这些发现表明,在老龄化社会中,普遍需要提高安全用药知识,这在LTCF工作的医护人员中可能尤为重要。版权所有© 2016 John Wiley & Sons, Ltd.